Hubei FTSCI BioTech Co.,Ltd.

Hubei FTSCI Biotech, founded in December 2014 (with roots to a 2012-2013 pilot phase) and headquartered in the National Incubator of Bio-Pharmaceutical Park in Wuhan's Donghu New Technology Development Zone, manufactures finished dosage forms and reagents supported by a complete analytical testing system including UPLC-MS, LC-MS, UPLC, and HPLC, staffed by technical team members with prior experience at SGS and WuXi PharmaTech. The company was certified a National High-tech Enterprise in 2018, jointly operates an expert workstation with Wuhan University, and has applied for more than 40 patents (13 approved) alongside 12 registered trademarks under its FTSCI brand, which it introduced at the CPhI China exhibition in 2019. Offering CRO, CMO, and CDMO services under OEM and its own brand, the company accepts T/T, L/C, Western Union, and MoneyGram payment and ships to North America, Central/South America, Western and Eastern Europe, Asia, and the Middle East.